Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma

Oncolytic viral (OV) therapies are promising novel treatment modalities for cancers refractory to conventional treatment, such as glioblastoma, within the central nervous system (CNS). Although OVs have received regulatory approval for use in the CNS, efficacy is hampered by obstacles related to del...

Descripción completa

Detalles Bibliográficos
Autores principales: Karandikar, Paramesh V., Suh, Lyle, Gerstl, Jakob V. E., Blitz, Sarah E., Qu, Qing Rui, Won, Sae-Yeon, Gessler, Florian A., Arnaout, Omar, Smith, Timothy R., Peruzzi, Pier Paolo, Yang, Wei, Friedman, Gregory K., Bernstock, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582965/
https://www.ncbi.nlm.nih.gov/pubmed/37860820
http://dx.doi.org/10.3389/fcell.2023.1271575

Ejemplares similares

Ejemplares similares